Heart patients may get sleep apnea test by mail in landmark trial

NCT ID NCT06618417

Recruiting now Knowledge-focused Sponsor: Herlev and Gentofte Hospital Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This trial tests whether mailing a sleep apnea home-testing device to people with atrial fibrillation can improve their quality of life. About 936 participants will either receive the device and possible treatment, or no test at all. Researchers will track symptoms, activity, and heart rhythm using a smartphone app over 18 weeks.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: sleep apnea home-evaluation device
What this could lead to: If successful, this could show that home testing for sleep apnea helps improve well-being and heart symptoms in people with atrial fibrillation.
What could go wrong: This is a large but early-stage trial focused on screening, not treatment. The benefit may be small or not apply to everyone. Results depend on participants accurately using the app and device.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION (AF) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atrial fibrillation sleep apnea syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ATRIAL FIBRILLATION (AF) SLEEP APNEA

Contacts and locations

Locations

Herlev-Gentofte Hospital
RECRUITING

Hellerup, 2900, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.